Tajikistan Receives New Packages of AstraZeneca and Pfizer-BioNTech
Read also
DUSHANBE, 15.11.2021 (NIAT Khovar) – On November 14, Tajikistan received 192,000 doses of the AstraZeneca vaccine and 117,000 doses of the Pfizer-BioNTech vaccine as part of the COVAX mechanism and the program for the fair distribution of the COVID-19 vaccine, reports the Ministry of Health and Social Protection of the Population.
Today, the United States delivered 117,000 out of 198,900 doses of the Pfizer vaccine to Tajikistan for the continued fight against the COVID-19 pandemic through the USAID and the COVAX facility. The remaining 81,900 doses will arrive this week. This latest donation adds to the 325,260 Pfizer doses that were delivered in September, and 1.5 million Moderna doses delivered in July 2021.
Also, this morning, the Republic of Latvia sent 60,000 doses of the AstraZeneca vaccine to Tajikistan as humanitarian aid.
The reception ceremony was attended by representatives of the Ministry of Health and Social Protection of the Population and other officials.
According to the decision of the Republican COVID-19 Prevention Commission, vaccination is mandatory for citizens over 18 years old.
The vaccine is provided to the citizens free of charge.









Flood Aftermath in Rushon District Under Government Supervision
Nearly 1,000 women entrepreneurs apply for Tajikistan’s 2026 presidential grants
Heatwave with temperatures up to 46°C expected in Tajikistan from July 16 to 19
Emomali Rahmon: «Rule of law is key to state stability and peaceful society»
Hot Weather with Temperatures up to 46°C Forecast in Tajikistan from July 15 to 18
Flash Floods Cause Significant Damage in Villages of Ayni District
Soil From Burial Sites of Tajik Heroes to Be Returned to Dushanbe
Tajikistan and Kyrgyzstan Aim to Deepen Healthcare Partnership
Tajikistan Holds First Meeting on Pandemic Fund Grants
Tajikistan, U.S Sign Health Cooperation Memorandum Through 2030
Committee for Youth and Sports Affairs Announces 2026 Ismoil Somoni Prize for Young Scientists





